Cancer Diagnostics Market Global Competing Analysis

Dallas, TX -- (SBWIRE) -- 02/18/2013 -- RnRMarketResearch.com adds “Competing in the Global Cancer Diagnostics Market” new market research report to its store. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Highlights on Competing in the Global Cancer Diagnostics Market:
- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years
- Examines trends in the U.S., Europe and Japan
- Reviews current and emerging tumor markers
- Analyzes applications of emerging diagnostic technologies
- Forecasts sales of major tumor markers by country and market segment
- Profiles leading market players and potential entrants
- Suggests alternative business expansion strategies for suppliers.

Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Market Segmentation Analysis
- Sales and market shares of major suppliers, by individual tumor marker and country.
- Five-year test volume and sales forecasts for major tumor markers by country and market
segment, including:
o Hospitals
o Commercial/Private Laboratories
o Physician Offices/Group Practices
o Cancer Clinics
o Ambulatory Care Centers
- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
- Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.
Current and Emerging Products
- Review of over 200 current and emerging tumor markers, including:
o Biochemical Markers
o Oncogenes
o Growth Factors
o Hormones
o Colony Stimulating Factors
o Lymphokines
o Immunohistochemical Stains, and others.
- Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices.

Technology Review
- Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for tumor marker testing.
- Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.
- Extensive listings of over 500 companies, universities and research centers developing new tumor markers and detection technologies.

Competitive Assessments
Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Worldwide Market Overview
- Estimated universe of laboratories performing tumor marker testing by country.
- Five-year test volume and sales projections by country.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Buy your copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=75151. Contact sales@rnrmarketresearch.com for further information.

Connect US:
Twitter: https://twitter.com/RnRMR
Facebook: http://www.facebook.com/pages/RnR-Market-Research/413488545356345
Google Plus: https://plus.google.com/u/0/104156468549256253075/posts